Abstract:Aim: Although aberrant miRNAs expression has been documented, altered miR-100 expression in cervical cancer and precursor tissues and its carcinogenic effect and mechanism remain unexplored. The aim of our study was to investigate the role of miR-100 alteration in cervical carcinogenesis.Methods: The expression of miR-100 was examined by quantitative real-time reverse transcriptase PCR (qRT-PCR) in 125 cervical tissues including normal cervical epithelium, cervical intraepithelial neoplasia (CIN), and cervical cancer, as well as in five cervical cell lines. Through modulating miR-100 expression using miR-100 inhibitor or mimic in vitro, cell growth, cycle and apoptosis were tested separately by MTT or flow cytometry and meanwhile Polo-like kinase1 (PLK1) mRNA and protein expressions were detected by qRT-PCR and immunoblotting. The expression of PLK1 in 125 cervical tissues was also examined by immunohistochemical staining and the correlation between miR-100 and PLK1 expression in the same tissues was analysed. Finally, HPV-16 E6/E7 expression was modulated by gene transfection and subsequently the level of miR-100 was examined by qRT-PCR.Results: The miR-100 expression showed a significantly and gradually reduced tendency from low-grade CIN, high-grade CIN to cervical cancer tissues and a significant decrease in HPV positive cervical cancer cell lines. The modulation of miR-100 expression remarkably influenced cell proliferation, cycle and apoptosis, as well as the level of PLK1 protein, but not mRNA, in vitro experiments. PLK1 expression was negatively correlated with miR-100 expression in CIN3 and cervical cancer tissues. The modulation of HR-HPV E6/E7 expression did not change miR-100 level.Conclusions: The reduced miR-100 expression participates in the development of cervical cancer at least partly through loss of inhibition to target gene PLK1, which probably occurs in a relative late phase of carcinogenesis. HR-HPV E6/E7 may not directly regulate miR-100 expression in cervical cells. (C) 2011 Elsevier Ltd. All rights reserved.

Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential.

Multiple Roles of MicroRNA-100 in Human Cancer and Its Therapeutic Potential

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

Function of Microrna-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment

Potential role of miR-100 in cancer diagnosis, prognosis, and therapy

Reduced Mir-100 Expression in Cervical Cancer and Precursors and Its Carcinogenic Effect Through Targeting PLK1 Protein.

Functions and Underlying Mechanisms of Mir-650 in Human Cancers

Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

The Roles of MicroRNA-141 in Human Cancers: from Diagnosis to Treatment

The roles and clinical significance of microRNAs in cervical cancer.

The Diverse Oncogenic and Tumor Suppressor Roles of Microrna-105 in Cancer

Multifaceted role of microRNA-301a in human cancer: from biomarker potential to therapeutic targeting

Molecular Mechanisms and Roles of MiR-136-5p in Human Cancer and Other Disorders

The Versatile Role of Microrna-30A in Human Cancer.

MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment

How MicroRNAs Command the Battle against Cancer

Roles and mechanisms of miR-195-5p in human solid cancers

Prognostic role of microRNA-100 in various carcinomas: evidence from six studies